These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18923385)

  • 21. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1).
    Takahashi T; Ono H; Ono Y; Ishimitsu T; Matsuoka H
    Int Heart J; 2007 Sep; 48(5):637-47. PubMed ID: 17998773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone.
    Mejía-Vilet JM; Ramírez V; Cruz C; Uribe N; Gamba G; Bobadilla NA
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F78-86. PubMed ID: 17376767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium nitroprusside and L-arginine attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats.
    Gupta A; Chander V; Sharma S; Chopra K
    Toxicology; 2007 Apr; 232(3):183-91. PubMed ID: 17280760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.
    Rocha R; Stier CT; Kifor I; Ochoa-Maya MR; Rennke HG; Williams GH; Adler GK
    Endocrinology; 2000 Oct; 141(10):3871-8. PubMed ID: 11014244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats.
    Ito K; Chen J; Seshan SV; Khodadadian JJ; Gallagher R; El Chaar M; Vaughan ED; Poppas DP; Felsen D
    Kidney Int; 2005 Aug; 68(2):515-28. PubMed ID: 16014028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J
    Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
    Helle F; Iversen BM; Chatziantoniou C
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy.
    Tamada S; Nakatani T; Asai T; Tashiro K; Komiya T; Sumi T; Okamura M; Kim S; Iwao H; Kishimoto T; Yamanaka S; Miura K
    Kidney Int; 2003 Jan; 63(1):306-14. PubMed ID: 12472797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models.
    Sharkovska Y; Kalk P; Lawrenz B; Godes M; Hoffmann LS; Wellkisch K; Geschka S; Relle K; Hocher B; Stasch JP
    J Hypertens; 2010 Aug; 28(8):1666-75. PubMed ID: 20613628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats.
    Blasi ER; Rocha R; Rudolph AE; Blomme EA; Polly ML; McMahon EG
    Kidney Int; 2003 May; 63(5):1791-800. PubMed ID: 12675855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
    Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
    J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Viscum articulatum Burm. (Loranthaceae) in Nω-nitro-L-arginine methyl ester induced hypertension and renal dysfunction.
    Bachhav SS; Bhutada MS; Patil SD; Baser B; Chaudhari KB
    J Ethnopharmacol; 2012 Jul; 142(2):467-73. PubMed ID: 22626924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity.
    Ghaznavi R; Kadkhodaee M
    Arch Toxicol; 2007 Jun; 81(6):453-7. PubMed ID: 17039356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
    Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
    Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
    Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
    Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats.
    Paulis L; Pechanova O; Zicha J; Krajcirovicova K; Barta A; Pelouch V; Adamcova M; Simko F
    J Hypertens Suppl; 2009 Aug; 27(6):S11-6. PubMed ID: 19633445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.